Antiphospholipid Abs in patients with SSc
| Patient No | Thrombosis | Anti-PS/PT Ab (U/ml) | Lupus anticoagulant | Anti-CL/β2GPI Ab |
|---|---|---|---|---|
| CL/β2GPI, cardiolipin/β2-glycoprotein I complex; ND, not done. | ||||
| 1 | + Deep vein | + 104 | − | − |
| 2 | + Deep vein | + 35.2 | + | − |
| 3 | − | + 29.5 | + | − |
| 4 | − | + 29 | − | − |
| 5 | + Heart | + 24.5 | + | − |
| 6 | − | + 24.5 | ND | ND |
| 7 | + Brain | + 22 | + | − |
| 8 | + Brain | + 19.3 | + | + |
| 9 | + Deep vein | + 19.1 | − | − |
| 10 | − | + 18.2 | + | − |
| 11 | − | + 17 | − | − |
| 12 | − | + 17 | + | − |
| 13 | − | + 15.4 | ND | ND |
| 14 | − | + 15.1 | − | − |
| 15 | − | + 14 | − | − |
| 16 | − | + 13.3 | + | − |
| 17 | − | + 13.2 | + | − |
| 18 | − | + 13 | ND | ND |
| 19 | − | − 9.1 | + | + |
| 20 | + Heart | − 8.8 | + | − |
| 21 | + Deep vein | − 8.8 | + | + |
| 22 | − | − 8.1 | + | − |
| 23 | − | − 7.6 | + | + |
| 24 | − | − 6.8 | + | − |
| 25 | + Deep vein | − 6.2 | + | − |
| 26 | − | − <5 | + | − |
| 27 | − | − <5 | + | ND |
| 28 | − | − <5 | + | − |
| 29 | − | − <5 | + | − |
| 30 | − | − <5 | + | − |